+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pediatric Preventable Vaccine Market - Global Forecast 2025-2030- Product Image
Pediatric Preventable Vaccine Market - Global Forecast 2025-2030- Product Image
Sale

Pediatric Preventable Vaccine Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6136520
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Decision-makers seeking to optimize pediatric immunization strategies face an evolving market shaped by regulatory changes, technology advancement, and increasing global collaboration. This report provides in-depth clarity on the pediatric vaccine market, highlighting critical shifts that influence sourcing, manufacturing, and deployment for childhood disease prevention.

Market Snapshot: Pediatric Vaccine Market Overview

The pediatric vaccine market is characterized by robust growth, underpinned by innovative delivery technologies and evolving policy frameworks. Key players are aligning advanced manufacturing with adaptive regulatory approvals, supporting high immunization rates across major regions. Increased cross-sector collaboration and resilient supply chains continue to propel adoption of essential preventable vaccines, reinforcing positive outcomes in public health and global well-being.

Pediatric Vaccine Market Scope & Segmentation

This report delivers a comprehensive segmentation to enable strategic planning and targeted market entry.

  • Vaccine Types: Diphtheria Tetanus Pertussis, Haemophilus Influenzae Type B, Hepatitis B, Measles Mumps Rubella, Pneumococcal Conjugate, Polio, Varicella
  • Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Government Programs, International Aid, Community Health Clinics, Private Clinics, Public Hospitals, Private Hospitals, Community Camps, Mobile Clinics
  • End Users: Clinics (Community Health, Private), Hospitals (Private, Public), Outreach Centers (Community Camps, Mobile Clinics)
  • Age Groups: Adolescence, Infant, Neonate, Preschool, School Age, Toddler
  • Technologies: Conjugate, Inactivated, Live Attenuated, Subunit, Toxoid
  • Routes of Administration: Injection, Nasal, Oral
  • Dosage Forms: Multi Dose, Single Dose
  • Geographic Regions: Americas (United States [California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio], Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Key Companies: GlaxoSmithKline plc, Sanofi S.A., Pfizer Inc., Merck & Co., Inc., CSL Limited, Serum Institute of India Private Limited, Bharat Biotech International Limited, Takeda Pharmaceutical Company Limited, Bavarian Nordic A/S, Emergent BioSolutions Inc.

Key Takeaways for Senior Leaders

  • Recent advances in conjugate and subunit technologies are enabling more targeted immunogenic responses and longer-term pediatric protection.
  • Policy shifts have streamlined regulatory processes, encouraging adaptive approvals while supporting robust safety oversight.
  • Integrated data ecosystems and digital supply tracking have enhanced cold chain management, improving vaccine integrity from manufacture to delivery.
  • Public-private partnerships and global collaborations are ensuring wider vaccine access, particularly in underserved and remote communities.
  • Segmentation across age groups, technology types, and administration routes supports highly tailored immunization schedules, aligning with diverse healthcare environments.
  • Manufacturers focused on geographic diversification and localized production are better positioned to navigate trade-related disruptions and reduce distribution risks.

Pediatric Vaccine Market Tariff Impact

New U.S. trade tariffs on raw materials, adjuvants, and packaging have increased procurement costs and driven changes in sourcing strategies among manufacturers. Organizations are both renegotiating contracts and exploring regional production to manage exposure to tariffs, while adjusting logistics and cold chain protocols for longer transit times. Stakeholders are actively engaging with regulators to assess long-term public health impacts and advocate tariff relief to safeguard both affordability and supply continuity.

Methodology & Data Sources

This research integrates primary interviews with key stakeholders in vaccine manufacturing, distribution, and public health. Secondary analysis incorporates peer-reviewed publications, regulatory documents, and case studies. Triangulation and expert validation enhance reliability and ensure actionable insights. All data sources are documented to support transparency and reproducibility.

Why This Report Matters for Decision-Makers

  • Clarifies the pediatric immunization market’s current state and expected future direction, enabling informed investment and operational planning.
  • Equips industry leaders with evidence-based recommendations on supply chain, policy navigation, and technology adoption amid shifting trade and regulatory contexts.
  • Facilitates risk mitigation and opportunity identification by illuminating region-specific dynamics and segmentation insights relevant for strategic market positioning.

Conclusion

Comprehensive analysis of the pediatric vaccine market reveals an industry characterized by innovation, collaboration, and dynamic regulatory adaptation. Decision-makers equipped with these insights can drive impactful strategies to advance immunization, support resilient supply chains, and improve child health outcomes worldwide.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increased global uptake of maternal immunization programs to protect newborns against pertussis and influenza
5.2. Integration of digital health records to optimize pediatric vaccine schedule adherence and monitoring
5.3. Development of next generation mRNA-based vaccines targeting RSV and influenza in infants
5.4. Expansion of school-based vaccination initiatives to improve coverage rates for underprivileged children
5.5. Growing emphasis on equity-driven vaccine distribution to reduce disparities in pediatric immunization
5.6. Advancements in thermostable vaccine formulations for cold chain-independent delivery in remote regions
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Pediatric Preventable Vaccine Market, by Vaccine Type
8.1. Introduction
8.2. Diphtheria Tetanus Pertussis
8.3. Haemophilus Influenzae Type B
8.4. Hepatitis B
8.5. Measles Mumps Rubella
8.6. Pneumococcal Conjugate
8.7. Polio
8.8. Varicella
9. Pediatric Preventable Vaccine Market, by Distribution Channel
9.1. Introduction
9.2. Private Sector
9.2.1. Hospital Pharmacies
9.2.2. Retail Pharmacies
9.3. Public Sector
9.3.1. Government Programs
9.3.2. International Aid
10. Pediatric Preventable Vaccine Market, by End User
10.1. Introduction
10.2. Clinics
10.2.1. Community Health Clinics
10.2.2. Private Clinics
10.3. Hospitals
10.3.1. Private Hospitals
10.3.2. Public Hospitals
10.4. Outreach Centers
10.4.1. Community Camps
10.4.2. Mobile Clinics
11. Pediatric Preventable Vaccine Market, by Age Group
11.1. Introduction
11.2. Adolescence
11.3. Infant
11.4. Neonate
11.5. Preschool
11.6. School Age
11.7. Toddler
12. Pediatric Preventable Vaccine Market, by Technology
12.1. Introduction
12.2. Conjugate
12.3. Inactivated
12.4. Live Attenuated
12.5. Subunit
12.6. Toxoid
13. Pediatric Preventable Vaccine Market, by Route Of Administration
13.1. Introduction
13.2. Injection
13.3. Nasal
13.4. Oral
14. Pediatric Preventable Vaccine Market, by Dosage Form
14.1. Introduction
14.2. Multi Dose
14.3. Single Dose
15. Americas Pediatric Preventable Vaccine Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Pediatric Preventable Vaccine Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Pediatric Preventable Vaccine Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. GlaxoSmithKline plc
18.3.2. Sanofi S.A.
18.3.3. Pfizer Inc.
18.3.4. Merck & Co., Inc.
18.3.5. CSL Limited
18.3.6. Serum Institute of India Private Limited
18.3.7. Bharat Biotech International Limited
18.3.8. Takeda Pharmaceutical Company Limited
18.3.9. Bavarian Nordic A/S
18.3.10. Emergent BioSolutions Inc.
19. ResearchAI20. ResearchStatistics21. ResearchContacts22. ResearchArticles23. Appendix
List of Figures
FIGURE 1. PEDIATRIC PREVENTABLE VACCINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 18. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. PEDIATRIC PREVENTABLE VACCINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. PEDIATRIC PREVENTABLE VACCINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. PEDIATRIC PREVENTABLE VACCINE MARKET: RESEARCHAI
FIGURE 30. PEDIATRIC PREVENTABLE VACCINE MARKET: RESEARCHSTATISTICS
FIGURE 31. PEDIATRIC PREVENTABLE VACCINE MARKET: RESEARCHCONTACTS
FIGURE 32. PEDIATRIC PREVENTABLE VACCINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PEDIATRIC PREVENTABLE VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DIPHTHERIA TETANUS PERTUSSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DIPHTHERIA TETANUS PERTUSSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY HAEMOPHILUS INFLUENZAE TYPE B, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY HAEMOPHILUS INFLUENZAE TYPE B, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY HEPATITIS B, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY HEPATITIS B, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY MEASLES MUMPS RUBELLA, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY MEASLES MUMPS RUBELLA, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PNEUMOCOCCAL CONJUGATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PNEUMOCOCCAL CONJUGATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY POLIO, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY POLIO, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY VARICELLA, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY VARICELLA, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PRIVATE SECTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PRIVATE SECTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PRIVATE SECTOR, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PRIVATE SECTOR, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PUBLIC SECTOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PUBLIC SECTOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY GOVERNMENT PROGRAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY GOVERNMENT PROGRAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY INTERNATIONAL AID, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY INTERNATIONAL AID, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PUBLIC SECTOR, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PUBLIC SECTOR, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY COMMUNITY HEALTH CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY COMMUNITY HEALTH CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY OUTREACH CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY OUTREACH CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY COMMUNITY CAMPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY COMMUNITY CAMPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY MOBILE CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY MOBILE CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY OUTREACH CENTERS, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY OUTREACH CENTERS, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY ADOLESCENCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY ADOLESCENCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY INFANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY INFANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY NEONATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY NEONATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PRESCHOOL, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PRESCHOOL, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY SCHOOL AGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY SCHOOL AGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY TODDLER, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY TODDLER, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY CONJUGATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY CONJUGATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY INACTIVATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY SUBUNIT, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY SUBUNIT, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY TOXOID, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY TOXOID, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY NASAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY NASAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY MULTI DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY SINGLE DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PRIVATE SECTOR, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PRIVATE SECTOR, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PUBLIC SECTOR, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PUBLIC SECTOR, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY OUTREACH CENTERS, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY OUTREACH CENTERS, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PRIVATE SECTOR, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PRIVATE SECTOR, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PUBLIC SECTOR, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PUBLIC SECTOR, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY OUTREACH CENTERS, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY OUTREACH CENTERS, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 161. CANADA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 162. CANADA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 163. CANADA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. CANADA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. CANADA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PRIVATE SECTOR, 2018-2024 (USD MILLION)
TABLE 166. CANADA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PRIVATE SECTOR, 2025-2030 (USD MILLION)
TABLE 167. CANADA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PUBLIC SECTOR, 2018-2024 (USD MILLION)
TABLE 168. CANADA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PUBLIC SECTOR, 2025-2030 (USD MILLION)
TABLE 169. CANADA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. CANADA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. CANADA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 172. CANADA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 173. CANADA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 174. CANADA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 175. CANADA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY OUTREACH CENTERS, 2018-2024 (USD MILLION)
TABLE 176. CANADA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY OUTREACH CENTERS, 2025-2030 (USD MILLION)
TABLE 177. CANADA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 178. CANADA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 179. CANADA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 180. CANADA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 181. CANADA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 182. CANADA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 183. CANADA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 184. CANADA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 185. MEXICO PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 186. MEXICO PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 187. MEXICO PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 188. MEXICO PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 189. MEXICO PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PRIVATE SECTOR, 2018-2024 (USD MILLION)
TABLE 190. MEXICO PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PRIVATE SECTOR, 2025-2030 (USD MILLION)
TABLE 191. MEXICO PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PUBLIC SECTOR, 2018-2024 (USD MILLION)
TABLE 192. MEXICO PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PUBLIC SECTOR, 2025-2030 (USD MILLION)
TABLE 193. MEXICO PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. MEXICO PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. MEXICO PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 196. MEXICO PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 197. MEXICO PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 198. MEXICO PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 199. MEXICO PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY OUTREACH CENTERS, 2018-2024 (USD MILLION)
TABLE 200. MEXICO PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY OUTREACH CENTERS, 2025-2030 (USD MILLION)
TABLE 201. MEXICO PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 202. MEXICO PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 203. MEXICO PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 204. MEXICO PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 205. MEXICO PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 206. MEXICO PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 207. MEXICO PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 208. MEXICO PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PRIVATE SECTOR, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PRIVATE SECTOR, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PUBLIC SECTOR, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PUBLIC SECTOR, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY OUTREACH CENTERS, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY OUTREACH CENTERS, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PRIVATE SECTOR, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PRIVATE SECTOR, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PUBLIC SECTOR, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PUBLIC SECTOR, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY OUTREACH CENTERS, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY OUTREACH CENTERS, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PRIVATE SECTOR, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PRIVATE SECTOR, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PUBLIC SECTOR, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PUBLIC SECTOR, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY OUTREACH CENTERS, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY OUTREACH CENTERS, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PRIVATE SECTOR, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PRIVATE SECTOR, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PUBLIC SECTOR, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY PUBLIC SECTOR, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY OUTREACH CENTERS, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY OUTREACH CENTERS, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 302. UNITED KINGDOM PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 303. UNITED KINGDOM PEDIATRIC PREVENTABLE VACCINE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 304. UNITED KINGDOM PEDIATRIC PRE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Pediatric Preventable Vaccine Market report include:
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Pfizer Inc.
  • Merck & Co., Inc.
  • CSL Limited
  • Serum Institute of India Private Limited
  • Bharat Biotech International Limited
  • Takeda Pharmaceutical Company Limited
  • Bavarian Nordic A/S
  • Emergent BioSolutions Inc.

Related Topics

Related Reports

Adult Preventable Vaccines Market - Global Forecast 2025-2030 - Product Image

Adult Preventable Vaccines Market - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Pediatric Vaccine: Market Share, and Growth Analysis by Product Type (Combination Vaccines, Monovalent Vaccines), Application, End User, Technology - Product Image

Pediatric Vaccine: Market Share, and Growth Analysis by Product Type (Combination Vaccines, Monovalent Vaccines), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Preventable Vaccines - Global Strategic Business Report - Product Image

Preventable Vaccines - Global Strategic Business Report

  • Report
  • 391 Pages
  • Global
From
Quadracel Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts - Product Image

Quadracel Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

  • Report
  • 175 Pages
  • Global
From
Adult Vaccine Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

Adult Vaccine Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.